- Genetic basis of hypertrophic cardiomyopathy
- Award date
- 15 January 2010
- Number of pages
- Document type
- PhD thesis
- Faculty of Medicine (AMC-UvA)
The understanding of hypertrophic cardiomyopathy (HCM) has matured from its cornerstone as a disease of the sarcomere to a compendium of diseases with various clinical, genetic and morphologic substrates. Research has provided us more insights into i) the pathogenetic development of HCM, ii) the possible pro-hypertrophic pathways that are triggered, and iii) the modifiers that influence the disease phenotypes. These findings have opened the door for individualized medicine and the development of therapeutic trials aimed at disease prevention or slowing of disease progression in patients with genotype positive, hypertrophy negative HCM. However, far more research is needed to understand its exact pathogenic pathways, discover novel drug targets or understand and prevent its devastating feature of sudden cardiac death.
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library, or send a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.